Changes in the Gustave Roussy Immune Score as a Powerful Prognostic Marker of the Therapeutic Sensitivity of Nivolumab in Advanced Gastric Cancer: A Multicenter, Retrospective Study

Background Identification of positive biomarkers for the effects of nivolumab on patients with advanced gastric cancer (AGC) is significant. The Gustave Roussy Immune Score (GRIm-s) is associated with therapeutic resistance of immune checkpoint inhibitors (ICIs) in other cancers. This multicenter, r...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of surgical oncology 2022-11, Vol.29 (12), p.7400-7406
Hauptverfasser:	Nakazawa, Nobuhiro, Sohda, Makoto, Ubukata, Yasunari, Kuriyama, Kengo, Kimura, Akiharu, Kogure, Norimichi, Hosaka, Hisashi, Naganuma, Atsushi, Sekiguchi, Masanori, Saito, Kana, Ogata, Kyoichi, Sano, Akihiko, Sakai, Makoto, Ogawa, Hiroomi, Shirabe, Ken, Saeki, Hiroshi
Format:	Artikel
Sprache:	eng
Schlagworte:	Disease control Gastric cancer Immune checkpoint inhibitors Immunotherapy Medical prognosis Medicine Medicine & Public Health Monoclonal antibodies Oncology Patients Risk groups Surgery Surgical Oncology Targeted cancer therapy Translational Research
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!